These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16250860)

  • 21. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
    J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
    JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients.
    Bunout D; Garrido A; Suazo M; Kauffman R; Venegas P; de la Maza P; Petermann M; Hirsch S
    Nutrition; 2000 Feb; 16(2):107-10. PubMed ID: 10696633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine and risk of cardiovascular disease.
    Andreotti F; Burzotta F; Manzoli A; Robinson K
    J Thromb Thrombolysis; 2000 Jan; 9(1):13-21. PubMed ID: 10590184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease.
    De Bree A; Verschuren WM; Kromhout D; Kluijtmans LA; Blom HJ
    Pharmacol Rev; 2002 Dec; 54(4):599-618. PubMed ID: 12429870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study.
    Voutilainen S; Tuomainen TP; Korhonen M; Mursu J; Virtanen JK; Happonen P; Alfthan G; Erlund I; North KE; Mosher MJ; Kauhanen J; Tiihonen J; Kaplan GA; Salonen JT
    PLoS One; 2007 Jan; 2(1):e181. PubMed ID: 17264883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype].
    González Ordóñez AJ; Medina Rodríguez JM; Fernández Alvarez CR; Sánchez García J; Fernández Carreira JM; Alvarez Martínez MV; Coto García E
    Med Clin (Barc); 2000 Jan; 114(1):7-12. PubMed ID: 10782453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
    Herrmann W; Lorenzl S; Obeid R
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying gene-environment interactions on the efficacy of folic acid therapy for hyperhomocysteinemia based on prediction model.
    Zhao Q; Li D; Huang X; Ren B; Yue L; Du B; Zhang C; Zhang W
    Nutr Res; 2020 May; 77():54-61. PubMed ID: 32320840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
    Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.
    Bostom AG; Gohh RY; Liaugaudas G; Beaulieu AJ; Han H; Jacques PF; Dworkin L; Rosenberg IH; Selhub J
    Atherosclerosis; 1999 Jul; 145(1):221-4. PubMed ID: 10428313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
    Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
    Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice.
    Zhou J; Møller J; Ritskes-Hoitinga M; Larsen ML; Austin RC; Falk E
    Atherosclerosis; 2003 Jun; 168(2):255-62. PubMed ID: 12801608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation.
    Koyama K; Usami T; Takeuchi O; Morozumi K; Kimura G
    Nephrol Dial Transplant; 2002 May; 17(5):916-22. PubMed ID: 11981084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
    Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis.
    Siri PW; Verhoef P; Kok FJ
    J Am Coll Nutr; 1998 Oct; 17(5):435-41. PubMed ID: 9791839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.